Legacy Wealth Partners (California)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$205K Buy
+1,816
New +$205K 0.11% 88
2020
Q3
Sell
-9,064
Closed -$890K 88
2020
Q2
$890K Buy
9,064
+4,856
+115% +$428K 0.67% 30
2020
Q1
$321K Buy
4,208
+14
+0.3% +$1.19K 0.3% 64
2019
Q4
$363K Buy
+4,194
New +$348K 0.26% 73

Other funds holding ABBV

Legacy Wealth Partners (California)'s ABBV Position: Q2 2021 in Review

Legacy Wealth Partners (California) opened a new position in AbbVie (ABBV) in Q2 2021: 1,816 shares worth $205K. The stake represents 0.11% of the portfolio and ranks #88 among its holdings. This is a return to the name: Legacy Wealth Partners (California) previously reported a position in ABBV as recently as Q2 2020.

Legacy Wealth Partners (California) first reported a position in ABBV in Q4 2019 and has held it in 4 quarters since. The position peaked at $890K in Q2 2020. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Legacy Wealth Partners (California) held 1,816 shares of AbbVie worth $205K as of Q2 2021.
  • AbbVie was a new Legacy Wealth Partners (California) position in Q2 2021.
  • AbbVie made up 0.11% of Legacy Wealth Partners (California)'s portfolio in Q2 2021, its #88 holding.
  • Legacy Wealth Partners (California) first reported a position in AbbVie in Q4 2019 and has held it in 4 quarters since.
  • Legacy Wealth Partners (California)'s AbbVie position peaked at $890K in Q2 2020.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Legacy Wealth Partners (California)'s 13F filing for Q2 2021, filed 16 Aug 2021.